Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 79387-69-2 | MDL No. : | MFCD00130245 |
Formula : | C4H3IN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PVHCYDBPRLPQMP-UHFFFAOYSA-N |
M.W : | 221.98 | Pubchem ID : | 11959096 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 37.57 |
TPSA : | 45.75 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.69 cm/s |
Log Po/w (iLOGP) : | 1.0 |
Log Po/w (XLOGP3) : | -0.05 |
Log Po/w (WLOGP) : | 0.37 |
Log Po/w (MLOGP) : | 0.38 |
Log Po/w (SILICOS-IT) : | 2.17 |
Consensus Log Po/w : | 0.78 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.74 |
Solubility : | 4.04 mg/ml ; 0.0182 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.46 |
Solubility : | 77.0 mg/ml ; 0.347 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.52 |
Solubility : | 0.675 mg/ml ; 0.00304 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.81 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | at 20℃; for 16 h; Darkness | To a solution of pyrimidin-2-ol hydrochloride (5) (12.306 g, 93 mmol) in methanol (357 ml) was added iodine (27.2 g, 107 mmol). The dark purple mixture was stirred at room temperature until all iodine had dissolved. Pulverized silver(I) sulfate (33.4 g, 107 mmol) was added, in one portion, and the mixture was allowed to stir for 16 h in the dark. The yellow Agl precipitate was filtered and the filter cake washed with methanol. The filtrate was treated dropwise with a 50percent aq. KOH solution until pH 10 forming a heavy white precipitate. The resulting alkaline mixture was neutralized (pH 7) with acetic acid and rotoevaporated to dryness in vacuo. The solid residue was suspended in boiling water (-500 mL) and allowed to boil for 30 minutes. Additional water was added portion wise and the heating was continued until a yellow solution was obtained. The solution was allowed to cool to room temperature and placed in fridge for three days. The resulting suspension was filtered with suction, washed with cold water and dried to give compound 6, 5-iodopyrimidin-2(lH)-one (19.34 g, 87 mmol, 94 percent yield) as a yellow solid. MR (500 MHz, DMSO-d6) δ 8.43 (s, 2H), 12.21 (s, 1H); LRMS (ESI) [M-H]- calculated for C1213C4H3IN20 221.9, found 220.9 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77.5% | With N-iodo-succinimide In N,N-dimethyl-formamide | EXAMPLE 3 1-(2-Deoxy-β-D-Ribofuranosyl)-5-iodo-2-pyrimidinone 2-Pyrimidinone (6 g, 62.44 mmol) and N-iodosuccinimide (14.7 g, 65.3 mmol) in dry DMF (30 ml) were stirred for 48 hours at room temperature with the exclusion of both light and moisture. The mixture was added to ether (50 ml) with stirring and the supernatant was decanted. The precipitate was collected by filtration, repeatedly washed with acetone and finally with methanol, until the filtrate became light yellow. After drying in vacuo the yellow granular product, 5-iodo-2(1H)-pyrimidinone, appeared to be pure by tlc and spectra, but the elemental analysis indicated that it was contaminated with a trace amount of DMF. Yield: 11.35 g (77.5percent). |
77.5% | With N-iodo-succinimide In N,N-dimethyl-formamide | EXAMPLE 3 1-(2-Deoxy-beta-D-Ribofuranosyl)-5-iodo-2-pyrimidinone 2-Pyrimidinone (6 g, 62.44 mmol) and N-iodosuccinimide (14.7 g, 65.3 mmol) in dry DMF (30 ml) were stirred for 48 hours at room temperature with the exclusion of both light and moisture. The mixture was added to ether (50 ml) with stirring and the supernatant was decanted. The precipitate was collected by filtration, repeatedly washed with acetone and finally with methanol, until the filtrate became light yellow. After drying in vacuo the yellow granular product, 5-iodo-2(1H)-pyrimidinone, appeared to be pure by tlc and spectra, but the elemental analysis indicated that it was contaminated with a trace amount of DMF. Yield: 11.35 g (77.5percent). |
[ 1122-44-7 ]
4-Amino-5-iodopyrimidin-2(1H)-one
Similarity: 0.81
[ 554-01-8 ]
4-Amino-5-methylpyrimidin-2(1H)-one
Similarity: 0.61
[ 1122-44-7 ]
4-Amino-5-iodopyrimidin-2(1H)-one
Similarity: 0.81
[ 554-01-8 ]
4-Amino-5-methylpyrimidin-2(1H)-one
Similarity: 0.61